Long Term Efficacy and Safety of Eryfotona AK-NMSC® in Patients With Actinic Keratosis
Phase 4
- Conditions
- Actinic Keratosis
- Interventions
- Device: Eryfotona AK-NMSC® creamOther: Sunscreen SPF 50+
- First Posted Date
- 2012-08-02
- Last Posted Date
- 2013-10-11
- Lead Sponsor
- ISDIN
- Target Recruit Count
- 50
- Registration Number
- NCT01656226
- Locations
- 🇮🇹
Dermatology Unit, Medical Department Arcispedale Santa Maria Nuova, Reggio Emilia, Italy
Efficacy and Safety of Lambdalina (Lidocaine Cream) Versus Placebo as an Anesthetic for Laser Hair Removal
Phase 2
Completed
- Conditions
- Local Anesthesia
- Interventions
- Drug: Lambdalina® (Lidocaine 4% cream)Drug: Placebo
- First Posted Date
- 2011-05-26
- Last Posted Date
- 2012-04-13
- Lead Sponsor
- ISDIN
- Target Recruit Count
- 42
- Registration Number
- NCT01360749
- Locations
- 🇪🇸
Clínica Dermatológica Campo De Felipe, Barcelona, Spain
🇪🇸Clínica Dermatológica Láser, Madrid, Spain
Open Label Extension (OLE) for the Patients Treated in the ISD002-P144-07 Study
- First Posted Date
- 2008-10-28
- Last Posted Date
- 2013-02-11
- Lead Sponsor
- ISDIN
- Target Recruit Count
- 38
- Registration Number
- NCT00781053
- Locations
- 🇵🇱
Gabinet Lekarski Internistyczno- Reumatologiezny, Wroclaw, Poland
🇩🇪Klinik und Poliklinik für Dermatologie und Vererologie, Köln, Germany
🇩🇪Herz- und Rheumazentrum Kerckhoff-Klinik, Bad Hauheim, Germany
Tolerability and Bioavailability of the P144 Peptide Inhibitor of TGF-β1 After Topical Administration in Healthy Volunteers
- First Posted Date
- 2008-04-11
- Last Posted Date
- 2008-11-05
- Lead Sponsor
- ISDIN
- Target Recruit Count
- 36
- Registration Number
- NCT00656825
- Locations
- 🇪🇸
Hospital Universitario Puerta de Hierro, Madrid, Spain
🇪🇸Clínica Universitaria de Navarra, Pamplona, Spain
Efficacy and Tolerability Study of Topical Ciclosporin in a Psoriasis Plaque Test
Phase 1
Completed
- Conditions
- Psoriasis
- Interventions
- First Posted Date
- 2007-12-21
- Last Posted Date
- 2008-11-05
- Lead Sponsor
- ISDIN
- Target Recruit Count
- 25
- Registration Number
- NCT00578370
- Locations
- 🇩🇪
Bioskin, Hamburg, Germany
Efficacy and Safety Study of p144 to Treat Skin Fibrosis in Systemic Sclerosis
- First Posted Date
- 2007-12-17
- Last Posted Date
- 2013-02-11
- Lead Sponsor
- ISDIN
- Target Recruit Count
- 56
- Registration Number
- NCT00574613
- Locations
- 🇩🇪
Kerckhoff Klinik, Bad Nauheim, Hesse, Germany
🇵🇱Centrum Miriada, Bialystok, Poland
🇬🇧Chapel Allerton Hospital, Leeds, United Kingdom
© Copyright 2025. All Rights Reserved by MedPath